ライフサイエンスコーパス: liquid chromatography-mass spectrometry

1 re detected using qTOF-LC-MS (time-of-flight-liquid chromatography-mass spectrometry).

2 es by both extraction methods as analyzed by liquid chromatography mass spectrometry.

3 Resonance spectroscopy and Ultra-Performance Liquid Chromatography Mass Spectrometry.

4 as conducted on extracts of PM samples using liquid chromatography mass spectrometry.

5 high purity and then analyzed thoroughly by liquid chromatography mass spectrometry.

6 mance liquid chromatography, and verified by liquid chromatography mass spectrometry.

7 enin, an enamel-forming protein, by nanoflow liquid chromatography mass spectrometry.

8 ity and compare well to results from NMR and liquid chromatography-mass spectrometry.

9 were processed and analyzed using label-free liquid chromatography-mass spectrometry.

10 Content of GE was measured by liquid chromatography-mass spectrometry.

11 each A. baumannii strain was measured using liquid chromatography-mass spectrometry.

12 ns of specialized metabolites detected using liquid chromatography-mass spectrometry.

13 actionation of tryptic digests before online liquid chromatography-mass spectrometry.

14 Cord and maternal vitamin D were assessed by liquid chromatography-mass spectrometry.

15 ated host components by using microscopy and liquid chromatography-mass spectrometry.

16 by partial resistance to restriction and by liquid chromatography-mass spectrometry.

17 rs (DEWs) was determined by high-performance liquid chromatography-mass spectrometry.

18 electively in HPAECs, which was confirmed by liquid chromatography-mass spectrometry.

19 g high-performance liquid chromatography and liquid chromatography-mass spectrometry.

20 ated label following immunoprecipitation and liquid chromatography-mass spectrometry.

21 Endocannabinoid levels were measured using liquid chromatography-mass spectrometry.

22 Thymidine levels were determined by liquid chromatography-mass spectrometry.

23 lyzed for 2HG concentration by reverse-phase liquid chromatography-mass spectrometry.

24 hat were subsequently identified by means of liquid chromatography-mass spectrometry.

25 was measured in spot urine samples by using liquid chromatography-mass spectrometry.

26 rrots on the basis of features determined by liquid chromatography-mass spectrometry.

27 identification of the unmodified analyte by Liquid Chromatography-Mass Spectrometry.

28 each period and analyzed by high-resolution liquid chromatography-mass spectrometry.

29 ts with and 9 without T1R were conducted via liquid chromatography-mass spectrometry.

30 g the growth in presence of vancomycin using liquid chromatography-mass spectrometry.

31 sured plasma lipids and acylcarnitines using liquid chromatography-mass spectrometry.

32 ynamic light scattering, zeta potential, and liquid chromatography-mass spectrometry.

33 ntrations in LS180 cells were assessed using liquid chromatography-mass spectrometry.

34 d with Trypanosoma brucei rhodesiense, using liquid chromatography-mass spectrometry.

35 quantified using UPLC-MS, ultra-performance liquid chromatography-mass spectrometry.

36 easurement of serum phenylacetylglutamine by liquid chromatography-mass spectrometry.

37 h plasma bile acid contents were analyzed by liquid chromatography/mass spectrometry.

38 y available fluorometric-enzymatic assay and liquid chromatography/mass spectrometry.

39 scle protein fractional synthesis rate using liquid chromatography/mass spectrometry.

40 r and 536 population controls using unbiased liquid chromatography/mass spectrometry.

41 s were identified by label-free quantitative liquid chromatography/mass spectrometry.

42 rometry, and nonvolatile organic analysis by liquid chromatography/mass spectrometry.

43 p. petals were first analyzed using standard liquid chromatography-mass spectrometry analyses of sepa

44 Liquid chromatography/mass spectrometry analyses were pe

45 mbrane-active peptides has been probed using liquid chromatography-mass spectrometry analysis of pept

46 pectrometry analysis of free amino acids and liquid chromatography-mass spectrometry analysis of prot

47 S followed by next-generation sequencing and liquid chromatography-mass spectrometry analysis of the

48 Liquid chromatography-mass spectrometry analysis was emp

49 Effluent analysis by liquid chromatography-mass spectrometry and disk agar bi

50 Whole saliva was analyzed by liquid chromatography-mass spectrometry and gas chromato

51 cids in cell culture combined with gel-based liquid chromatography-mass spectrometry and lipidome ana

52 o complementary mass spectrometry platforms: liquid chromatography-mass spectrometry and matrix-assis

53 We applied high-resolution liquid chromatography-mass spectrometry and multiplex cy

54 ovel systems biology approach by integrating liquid chromatography-mass spectrometry and reverse phas

55 dexetimide in the brain were evaluated using liquid chromatography-mass spectrometry and storage phos

56 D2, D3, D5, E1 and 17-HDHA, were measured by liquid chromatography-mass spectrometry and tested for a

57 reatment were analyzed using high-throughput liquid chromatography-mass spectrometry and were compare

58 n = 60), and healthy controls (n = 30) using liquid chromatography/mass spectrometry and spectrophoto

59 e identified by means of proteomic analysis (liquid chromatography-mass spectrometry) and Ingenuity P

60 ective fraction (30-100 kDa) was analyzed by liquid chromatography-mass spectrometry, and cathepsin D

61 We performed metabolic profiling using liquid chromatography/mass spectrometry applied to predi

62 f two new products, which were identified by liquid chromatography-mass spectrometry as diCQAs.

63 ead to unacceptable accuracy in quantitative liquid chromatography-mass spectrometry assays, especial

64 D [25(OH)D] with the use of high-performance liquid chromatography-mass spectrometry, assessed dietar

65 Lastly, MultiAlign was applied to liquid chromatography-mass spectrometry-based datasets o

66 ntial improvement in automatic probabilistic liquid chromatography-mass spectrometry-based metabolome

67 Samples were analyzed using liquid chromatography-mass spectrometry-based metabolomi

68 Ultra-high-performance liquid chromatography-mass spectrometry-based phenolic p

69 Accordingly, ultra-high-performance liquid chromatography-mass spectrometry-based phenolic p

70 tro reduction metabolite as a standard for a liquid chromatography-mass spectrometry-based quantitati

71 pplication of a high-throughput, large-scale liquid chromatography-mass spectrometry-based quantitati

72 ed sugars using a model peptide approach and liquid chromatography-mass spectrometry-based techniques

73 olites associated with VTE risk, we employed liquid chromatography-mass spectrometry-based untargeted

74 Herein, we developed a top-down liquid chromatography/mass spectrometry-based ("LC/MS+")

75 We performed liquid chromatography/mass spectrometry-based metabolite

76 Gas- and liquid chromatography/mass spectrometry-based profiling

77 A generic high-throughput bioaffinity liquid chromatography-mass spectrometry (BioMS) approach

78 ed by untargeted metabolomics carried out by liquid-chromatography-mass spectrometry cannot be unique

79 understand the role of Gal-3BP, we here used liquid chromatography-mass spectrometry combined with sp

80 Liquid chromatography-mass spectrometry confirmed that t

81 xic extracts using a hyphenated technique of liquid chromatography-mass spectrometry coupled with pri

82 oach for both nuclear magnetic resonance and liquid chromatography-mass spectrometry data from humans

83 is a free software tool that aligns multiple liquid chromatography-mass spectrometry datasets to one

84 phenylphosphonium bromide (SPTPP) coupled to liquid chromatography/mass spectrometry (derivatization-

85 Complementary liquid-chromatography/mass-spectrometry determinations o

86 ry (CapLC-MALDI-MS/MS), and ultraperformance liquid chromatography-mass spectrometry(E) (UPLC-MS(E)).

87 Using UV-vis spectroscopy, liquid chromatography, mass spectrometry, elemental anal

88 Cell wall fractionation and liquid chromatography-mass spectrometry experiments isol

89 hepatic arterial reperfusion and analyzed by liquid chromatography-mass spectrometry for energetic co

90 first time a metabolomics approach based on liquid chromatography-mass spectrometry for revealing su

91 ossible use of a metabolomics approach using liquid chromatography-mass spectrometry for their classi

92 (2)H-alpha-tocopherol were measured by using liquid chromatography-mass spectrometry from fasting (>1

93 we analyzed the fatty acyl lipidome of AF by liquid chromatography-mass spectrometry from patients in

94 Untargeted metabolomics by liquid chromatography-mass spectrometry generates data-r

95 UHPLC-MS(n) (Ultra High Performance Liquid Chromatography-Mass Spectrometry) high-throughput

96 ample prior to analysis via high-performance liquid chromatography mass spectrometry (HPLC-MS), but a

97 a (ETU) in food matrices by high-performance liquid chromatography-mass spectrometry (HPLC-LC/MS) was

98 g (PF), were evaluated with high performance liquid chromatography-mass spectrometry (HPLC-MS) and ga

99 and quantitatively by using high-performance liquid chromatography-mass spectrometry (HPLC-MS) and ga

100 tula macrosclereid cells, a high performance liquid chromatography-mass spectrometry (HPLC-MS) assay

101 n for developing a top-down high-performance liquid chromatography-mass spectrometry (HPLC-MS) platfo

102 alternative to conventional high-performance liquid chromatography-mass spectrometry (HPLC-MS) with e

103 ulture medium were analyzed by high-pressure liquid chromatography-mass spectrometry (HPLC-MS).

104 A liquid chromatography/mass spectrometry hydrophilic inte

105 rations were measured using ultraperformance liquid chromatography mass spectrometry in plasma sample

106 riety of techniques and finally evaluated by liquid chromatography-mass spectrometry in the capillary

107 mmunohistochemistry [IHC]) and PGD(2) (ELISA/liquid chromatography mass spectrometry) in relation to

108 rooctanoic acid (PFOA) concentrations, using liquid chromatography-mass spectrometry, in 184 colostru

109 dducts of PhIP and 4-ABP were identified, by liquid chromatography/mass spectrometry, in proteolytic

110 antification of 15 mycotoxins in cow milk by liquid chromatography-mass spectrometry, is presented.

111 designs was compared in conjunction with the liquid chromatography mass spectrometry (LC-MS) analysis

112 antibodies that has often been identified by liquid chromatography mass spectrometry (LC-MS) analysis

113 Liquid chromatography mass spectrometry (LC-MS) based sh

114 ntact monolayer-protected clusters (MPCs) by liquid chromatography mass spectrometry (LC-MS) could pr

115 a high-performance chemical isotope labeling liquid chromatography mass spectrometry (LC-MS) techniqu

116 Liquid chromatography mass spectrometry (LC-MS) was used

117 based on chemical isotope labeling (CIL) and liquid chromatography mass spectrometry (LC-MS) with a f

118 f phytochemical extracts were acquired using liquid chromatography mass spectrometry (LC-MS), then th

119 generated by chemical isotope labeling (CIL) liquid chromatography mass spectrometry (LC-MS).

120 omplex sample matrices using high-resolution liquid chromatography mass spectrometry (LC-MS).

121 omatography mass spectrometry (GC-MS/MS) and liquid chromatography mass spectrometry (LC-MS/MS) were

122 and identified by gel-based tandem nanoflow liquid chromatography mass spectrometry (LC-MS/MS).

123 For targeted protein quantification by liquid chromatography mass spectrometry (LC/MS), an opti

124 ards via the use of stable isotope labeling, liquid chromatography mass spectrometry (LC/MS), and hig

125 Here using a 96-well plate (liquid chromatography- mass spectrometry (LC-MS) based d

126 tric waveform ion mobility spectrometry with liquid chromatography-mass spectrometry (LC-FAIMS-MS) ha

127 icability of a label-free approach, enhanced liquid chromatography-mass spectrometry (LC-MS(E)), for

128 bsequent analysis of the residual protein by liquid chromatography-mass spectrometry (LC-MS) after gl

129 ift is underway in the field of quantitative liquid chromatography-mass spectrometry (LC-MS) analysis

130 Sensitive and selective liquid chromatography-mass spectrometry (LC-MS) analysis

131 itates significant prefractionation prior to liquid chromatography-mass spectrometry (LC-MS) analysis

132 lines and control lines were assessed using liquid chromatography-mass spectrometry (LC-MS) and gas

133 o extract and analyze isotopic patterns from liquid chromatography-mass spectrometry (LC-MS) and gas

134 Metabolite profiling (liquid chromatography-mass spectrometry (LC-MS) and gas

135 We applied high-resolution liquid chromatography-mass spectrometry (LC-MS) and tand

136 loci that were validated at global level by liquid chromatography-mass spectrometry (LC-MS) and the

137 A simple and reliable liquid chromatography-mass spectrometry (LC-MS) assay ha

138 of metabolites remains a major challenge in liquid chromatography-mass spectrometry (LC-MS) based un

139 of the epoxide group was also studied under liquid chromatography-mass spectrometry (LC-MS) conditio

140 Analysis of liquid chromatography-mass spectrometry (LC-MS) data req

141 evaluated using one public and two in-house liquid chromatography-mass spectrometry (LC-MS) data set

142 package that takes high resolution wide-scan liquid chromatography-mass spectrometry (LC-MS) data set

143 he follow up time period clustered, based on liquid chromatography-mass spectrometry (LC-MS) data, wi

144 s analysis tool for identifying N-glycans in liquid chromatography-mass spectrometry (LC-MS) data.

145 ge isomer is obtained from a straightforward liquid chromatography-mass spectrometry (LC-MS) experime

146 sion of peptide retention times in proteomic liquid chromatography-mass spectrometry (LC-MS) experime

147 d solid-phase extraction (MISPE) followed by liquid chromatography-mass spectrometry (LC-MS) for biom

148 nventional protein precipitation followed by liquid chromatography-mass spectrometry (LC-MS) for stud

149 on, we aimed at developing a method based on liquid chromatography-mass spectrometry (LC-MS) for the

150 Liquid chromatography-mass spectrometry (LC-MS) has been

151 Affinity capture liquid chromatography-mass spectrometry (LC-MS) intact a

152 A novel liquid chromatography-mass spectrometry (LC-MS) interfac

153 Liquid chromatography-mass spectrometry (LC-MS) is a hig

154 -performance chemical isotope labeling (CIL) liquid chromatography-mass spectrometry (LC-MS) is an en

155 ome based on chemical isotope labeling (CIL) liquid chromatography-mass spectrometry (LC-MS) is repor

156 Liquid chromatography-mass spectrometry (LC-MS) measurem

157 Contrary to the main steps of a typical liquid chromatography-mass spectrometry (LC-MS) metabolo

158 enriched PAHSAs enabled the development of a liquid chromatography-mass spectrometry (LC-MS) method t

159 by amino acids in cell culture (SILAC)-based liquid chromatography-mass spectrometry (LC-MS) method t

160 Thus, we used stable isotope liquid chromatography-mass spectrometry (LC-MS) methodol

161 P analysis and thereby developed an improved liquid chromatography-mass spectrometry (LC-MS) methodol

162 Liquid chromatography-mass spectrometry (LC-MS) methods

163 hromatography-mass spectrometry (GC/MS), and liquid chromatography-mass spectrometry (LC-MS) methods

164 Liquid chromatography-mass spectrometry (LC-MS) methods

165 In this study, we developed a liquid chromatography-mass spectrometry (LC-MS) N-glycan

166 e times in the millisecond range for typical liquid chromatography-mass spectrometry (LC-MS) peaks, e

167 which statistical treatment of raw data from liquid chromatography-mass spectrometry (LC-MS) precedes

168 diabetic (n = 6) and healthy (n = 6) dogs by liquid chromatography-mass spectrometry (LC-MS) profilin

169 Label-free peptide quantification in liquid chromatography-mass spectrometry (LC-MS) proteomi

170 We employed shotgun liquid chromatography-mass spectrometry (LC-MS) proteomi

171 studies of RNA modifications, we developed a liquid chromatography-mass spectrometry (LC-MS) techniqu

172 Liquid chromatography-mass spectrometry (LC-MS) technolo

173 as-phase stripping-derivatization coupled to liquid chromatography-mass spectrometry (LC-MS) to measu

174 netics and quadrupole time of flight (Q-TOF) liquid chromatography-mass spectrometry (LC-MS) to show

175 Liquid-liquid extraction couple with liquid chromatography-mass spectrometry (LC-MS) was appl

176 Liquid chromatography-mass spectrometry (LC-MS) was used

177 as chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), and liq

178 entified by proteolytic cleavage followed by liquid chromatography-mass spectrometry (LC-MS), but thi

179 phase extraction, followed by analysis using liquid chromatography-mass spectrometry (LC-MS), capilla

180 actices for each common analytical platform: liquid chromatography-mass spectrometry (LC-MS), gas chr

181 c in the area of metabolomics, choosing from liquid chromatography-mass spectrometry (LC-MS), gas chr

182 Using a combination of liquid chromatography-mass spectrometry (LC-MS), size ex

183 n conjunction with chemical isotope labeling liquid chromatography-mass spectrometry (LC-MS), to prov

184 Here, we report a liquid chromatography-mass spectrometry (LC-MS)-based ap

185 In spite of the liquid chromatography-mass spectrometry (LC-MS)-based de

186 ion, we have developed a simple yet powerful liquid chromatography-mass spectrometry (LC-MS)-based me

187 eristics and idiosyncrasies of postprocessed liquid chromatography-mass spectrometry (LC-MS)-based me

188 Liquid chromatography-mass spectrometry (LC-MS)-based me

189 edures for sample collection and processing, liquid chromatography-mass spectrometry (LC-MS)-based me

190 sitive strains of P. falciparum by combining liquid chromatography-mass spectrometry (LC-MS)-based pr

191 matrix effect is one of the main concerns in liquid chromatography-mass spectrometry (LC-MS)-driven b

192 onfirmed in a large cohort of patients using liquid chromatography-mass spectrometry (LC-MS).

193 abeled using the flow system and analyzed by liquid chromatography-mass spectrometry (LC-MS).

194 gel kinase assay (RIKA) with high-resolution liquid chromatography-mass spectrometry (LC-MS).

195 sistent with a conventional ELISA as well as liquid chromatography-mass spectrometry (LC-MS).

196 e analyzed for small molecule metabolites by liquid chromatography-mass spectrometry (LC-MS).

197 olic pathways and are commonly generated via liquid chromatography-mass spectrometry (LC-MS).

198 a suspension culture cells and identified by liquid chromatography-mass spectrometry (LC-MS).

199 ntracellular and extracellular methionine by liquid chromatography-mass spectrometry (LC-MS).

200 aration of intact proteins by reversed-phase liquid chromatography-mass spectrometry (LC-MS).

201 ntifying the oxidation level by both NMR and liquid chromatography-mass spectrometry (LC-MS).

202 obile phases that are compatible with online liquid chromatography-mass spectrometry (LC-MS).

203 drug-to-antibody ratio (DAR), as measured by liquid chromatography-mass spectrometry (LC-MS).

204 ic deconvolution of high-resolution GC-MS or liquid chromatography-mass spectrometry (LC-MS); and MS-

205 act protein expression profiles and top-down liquid chromatography-mass spectrometry (LC-MS/MS) facil

206 hin 1h, and the assay was performed by using liquid chromatography-mass spectrometry (LC-MS/MS) techn

207 In this study, we used liquid chromatography-mass spectrometry (LC-MS/MS) to in

208 this study, we used low- and high-resolution liquid chromatography-mass spectrometry (LC/MS) techniqu

209 bolomics data generated from high-resolution liquid chromatography-mass spectrometry (LC/MS).

210 med data-independent, parallel-fragmentation liquid chromatography/mass spectrometry (LC/MS(E)), foll

211 The method involves direct liquid chromatography/mass spectrometry (LC/MS) analysis

212 In this paper, we present a novel liquid chromatography/mass spectrometry (LC/MS) data pro

213 eaks and perform retention-time alignment in liquid chromatography/mass spectrometry (LC/MS) data.

214 Liquid chromatography/mass spectrometry (LC/MS) metaboli

215 A reversed-phase liquid chromatography/mass spectrometry (LC/MS) methodol

216 sylation of etanercept was carried out using liquid chromatography/mass spectrometry (LC/MS) methods

217 ds were characterised by combining different liquid chromatography/mass spectrometry (LC/MS) methods:

218 When using liquid chromatography/mass spectrometry (LC/MS) to perfo

219 ompounds, previously done with accurate mass liquid chromatography/mass spectrometry (LC/MS).

220 In this study we demonstrate that liquid-chromatography-mass spectrometry (LC-MS) can be u

221 Untargeted liquid-chromatography-mass spectrometry (LC-MS)-based me

222 ion using AHL biosensors and high resolution liquid chromatography-mass spectrometry (LCMS).

223 heir involvement during influenza infection, liquid chromatography/mass spectrometry lipidomic profil

224 Detailed product studies using liquid chromatography-mass spectrometry/mass spectrometr

225 tensin analysis was performed using a unique liquid chromatography-mass spectrometry/mass spectroscop

226 mbining state-of-the-art ultra-high-pressure liquid chromatography-mass spectrometry metabolic flux a

227 1N1 infection responses, we performed global liquid chromatography-mass spectrometry metabolic profil

228 A promising approach for mining liquid chromatography-mass spectrometry metabolite profi

229 Our pilot study using liquid chromatography-mass spectrometry metabolomics ana

230 n postprandially were analyzed by untargeted liquid chromatography-mass spectrometry metabolomics.

231 By using targeted liquid chromatography/mass spectrometry metabolomics, we

232 An accurate, simple and rapid liquid chromatography mass spectrometry method for the d

233 A liquid chromatography-mass spectrometry method was devel

234 Recent advances in liquid chromatography-mass spectrometry methods have ena

235 attainable using conventional reversed-phase liquid chromatography-mass spectrometry methods.

236 In nano-liquid chromatography-mass spectrometry (nano-LC-ESI-MS)

237 nce chemical isotope labeling (CIL) nanoflow liquid chromatography mass spectrometry (nanoLC-MS) for

238 We describe a robust nano liquid chromatography-mass spectrometry (nanoLC-MS) plat

239 counterterrorism purposes, a selective nano liquid chromatography-mass spectrometry (nanoLC-MS) plat

240 Nanoflow liquid chromatography mass spectrometry (nLC-MS) is freq

241 Normal phase liquid chromatography mass spectrometry (NP-LC-MS) was u

242 agnetic resonance spectroscopy and end point liquid chromatography/mass spectrometry of TG dynamics.

243 istry and electron microscopy, and performed liquid chromatography-mass spectrometry on optic gliomas

244 files were analyzed by ultrahigh-performance liquid chromatography-mass spectrometry over a period of

245 id phase microextraction method coupled to a liquid chromatography-mass spectrometry platform (DI-SPM

246 Here, an algorithm is presented in which liquid chromatography-mass spectrometry profiles are sea

247 ids are analyzed using an optimized nanoflow liquid chromatography/mass spectrometry protocol.

248 Liquid chromatography/mass spectrometry quantified BAs.

249 re measured with the use of immunoassays and liquid chromatography-mass spectrometry, respectively, i

250 ELISA, and urinary fumonisin B1 (UFB1) using liquid chromatography-mass spectrometry, respectively.

251 this study, metabololipidomic profiling via liquid chromatography mass spectrometry revealed higher

252 quantitative polymerase chain reaction, and liquid chromatography-mass spectrometry revealed a highe

253 Analysis of fractions by liquid chromatography-mass spectrometry revealed reliabl

254 the PWGPE was determined by rapid resolution liquid chromatography/mass spectrometry (RRLC/MS).

255 Through liquid chromatography-mass spectrometry screening of int

256 of the compounds using ultrahigh-performance liquid chromatography-mass spectrometry-solid-phase extr

257 t (15)N labeling can be used for large-scale liquid chromatography-mass spectrometry studies of prote

258 Analyses of the metabolites by liquid chromatography-mass spectrometry suggest differen

259 t injection of untreated wine samples into a liquid chromatography-mass spectrometry system, processi

260 ative and absolute quantitation-labeling and liquid chromatography-mass spectrometry, tandem mass spe

261 In liquid chromatography-mass spectrometry/tandem mass spec

262 in cows over the entire milking season using liquid chromatography-mass spectrometry technique.

263 A detailed evaluation of two liquid chromatography-mass spectrometry techniques, quad

264 emonstrate the ability to directly track, by liquid chromatography-mass spectrometry, the passage of

265 With the use of liquid chromatography-mass spectrometry-time-of-flight a

266 s to small oligosaccharides followed by fast liquid chromatography mass spectrometry to determine sam

267 of plasma metabolites using ultraperformance liquid chromatography mass spectrometry to identify pati

268 we used single-dimension ultra-high-pressure liquid chromatography mass spectrometry to investigate t

269 We used gas and liquid chromatography-mass spectrometry to analyze basel

270 In this study we utilized liquid chromatography-mass spectrometry to examine the e

271 tablish that BONCAT can be coupled to tandem liquid chromatography-mass spectrometry to identify and

272 oligonucleotide affinity chromatography and liquid chromatography-mass spectrometry to identify nucl

273 The method uses liquid chromatography-mass spectrometry to monitor the r

274 hly efficient 3-dimensional high performance liquid chromatography/mass spectrometry to enable quanti

275 lldown assays combined with high sensitivity liquid chromatography/mass spectrometry to identify nove

276 Using liquid chromatography-mass spectrometry, to our knowledg

277 As, we have developed a sensitive ultra fast liquid chromatography-mass spectrometry (UFLC-MS) method

278 Hyphenated ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) has be

279 alysis of data obtained by ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) measur

280 A rapid gradient microbore ultraperformance liquid chromatography-mass spectrometry (UPLC-MS) method

281 Exploratory or untargeted ultra performance liquid chromatography-mass spectrometry (UPLC-MS) profil

282 The ultra performance liquid chromatography-mass spectrometry (UPLC-MS)/MS tar

283 or which were detected by ultra-performance liquid chromatography-mass spectrometry (UPLC-MS/MS) in

284 m dogs using an established ultraperformance liquid chromatography-mass spectrometry (UPLC-MS/MS) pla

285 thout late-onset T2D using ultra-performance liquid-chromatography mass-spectrometry (UPLC-MS) to ide

286 chondrial lipid distribution was analyzed by liquid chromatography-mass spectrometry using HeLa cells

287 In this study, liquid chromatography-mass spectrometry was used for the

288 Comprehensive metabolomics analysis with liquid chromatography-mass spectrometry was used to dete

289 Liquid chromatography-mass spectrometry was used to dete

290 mino acids in cell culture and reverse-phase liquid chromatography mass spectrometry, we assessed the

291 Utilizing nanoflow liquid chromatography mass spectrometry, we identified 1

292 Using liquid chromatography mass spectrometry, we identified t

293 Using liquid chromatography-mass spectrometry, we analyzed 304

294 Using high-resolution liquid chromatography-mass spectrometry, we found that t

295 Using immunoaffinity liquid chromatography-mass spectrometry, we identified a

296 Using liquid chromatography-mass spectrometry, we measured 25(

297 Through bioinformatic analysis and liquid chromatography/mass spectrometry, we identified A

298 of mammalian cells and ultrasensitive tandem liquid-chromatography mass spectrometry, we show that th

299 racers measured by quadrupole time-of-flight liquid chromatography-mass spectrometry were used to qua

300 re measured with the use of high-performance liquid chromatography-mass spectrometry, were fit to a 7